I like the look of this one. Cancer stocks and Diagnostic stocks have been trending very well of late. This one is the combo. Approx. $40 mil of R & D has been spent on this beast cancer test to date so the current EV is more than reasonable.
BCAL is a gamechanger. Speak to your mum, wife, sister etc and ask if they like having their breasts squeezed between 2 metal plates which is the current ancient technique.
BCAL is a simple blood test that eventually women (and men actually) can just add to their anual check up when the doctor sends the blood sample to the pathology lab to test for everything else.
This is a game changing technology that could be worth billiions if successful.
Plus its a platform technology so that eventually other cancers can also be picked up from the blood sample.
